Activation of AKT signaling promotes epithelial–mesenchymal transition and tumor growth in colorectal cancer cells
暂无分享,去创建一个
T. Das | S. Suman | C. Damodaran | Chendil Damodaran | Suman Suman | Vittal Kurisetty | Trinath P Das | Aditi Vadodkar | Gabriel Ramos | Rajkumar Lakshmanaswamy | R. Lakshmanaswamy | V. Kurisetty | A. Vadodkar | Gabriel Ramos | Vittal Kurisetty
[1] P. Tsichlis,et al. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. , 1999, Annual review of biochemistry.
[2] F. Sipos,et al. Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon. , 2012, World journal of gastroenterology.
[3] Robert A. Weinberg,et al. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.
[4] A. Martelli,et al. The emerging multiple roles of nuclear Akt. , 2012, Biochimica et biophysica acta.
[5] Jongkyeong Chung,et al. Akt: versatile mediator of cell survival and beyond. , 2002, Journal of biochemistry and molecular biology.
[6] R. Pearson,et al. Targeting PI3 kinase/AKT/mTOR signaling in cancer. , 2012, Critical reviews in oncogenesis.
[7] T. Kume,et al. The Foxc2 transcription factor regulates tumor angiogenesis. , 2010, Biochemical and biophysical research communications.
[8] G. Sethi,et al. Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. , 2010, Biochimica et biophysica acta.
[9] J. Cheng,et al. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] B. Jiang,et al. PI3K/PTEN signaling in angiogenesis and tumorigenesis. , 2009, Advances in cancer research.
[11] J. Rubin,et al. Rapid, Wnt-Induced Changes in GSK3β Associations that Regulate β-Catenin Stabilization Are Mediated by Gα Proteins , 2005, Current Biology.
[12] R. Gaynor,et al. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. , 2003, Molecular biology of the cell.
[13] Kristina M. Cook,et al. Angiogenesis Inhibitors: Current Strategies and Future Prospects , 2010, CA: a cancer journal for clinicians.
[14] M. Guarino. Epithelial-mesenchymal transition and tumour invasion. , 2007, The international journal of biochemistry & cell biology.
[15] M. Malafa,et al. Targeting AKT protein kinase in gastric cancer. , 2011, Anticancer research.
[16] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[17] Yingwei Chen,et al. PI3K: A potential therapeutic target for cancer , 2012, Journal of cellular physiology.
[18] V. Steele,et al. Targeting the AKT protein kinase for cancer chemoprevention , 2007, Molecular Cancer Therapeutics.
[19] L. Nelles,et al. Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition , 2007, Oncogene.
[20] C. Heldin,et al. Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.
[21] Alfonso Bellacosa,et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.
[22] G. Berx,et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. , 2006, Gastroenterology.
[23] L. Milanesi,et al. Systems biology of the metabolic network regulated by the Akt pathway. , 2012, Biotechnology advances.
[24] P. Dennis,et al. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. , 2001, Cancer research.
[25] S. Sheng,et al. Metastasis and AKT activation , 2008, Cell cycle.
[26] M. Tatari,et al. EMT as the ultimate survival mechanism of cancer cells. , 2012, Seminars in cancer biology.
[27] Y. Rojanasakul,et al. Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.
[28] O. De Wever,et al. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[29] K. Green. Faculty Opinions recommendation of Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. , 2004 .
[30] F. Arvelo,et al. Biology of colorectal cancer , 2015, Ecancermedicalscience.
[31] Avri Ben-Ze'ev,et al. Autoregulation of E-cadherin expression by cadherin–cadherin interactions , 2003, The Journal of cell biology.
[32] G. Christofori. New signals from the invasive front , 2006, Nature.
[33] T. Das,et al. Induction of reactive oxygen species generation inhibits epithelial–mesenchymal transition and promotes growth arrest in prostate cancer cells , 2014, Molecular carcinogenesis.
[34] W. Fiers,et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.
[35] J. Rubin,et al. Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. , 2005, Current biology : CB.
[36] Domenico Coppola,et al. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer , 2000, Oncogene.
[37] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[38] J. Gordon,et al. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. , 1996, Genes & development.
[39] S. Sanyal,et al. Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling. , 2012, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[40] E. Avizienyte,et al. The Src-Induced Mesenchymal State in Late-Stage Colon Cancer Cells , 2005, Cells Tissues Organs.
[41] H. Weiss,et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. , 2011, Cancer research.
[42] G. Casey,et al. The AKT/IκB kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-κB and β-catenin , 2005, Oncogene.
[43] G. Casey,et al. The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin. , 2005, Oncogene.
[44] E. Woltering,et al. Do primary neuroendocrine tumors and metastasis have the same characteristics? , 2012, The Journal of surgical research.
[45] M. Sakamoto,et al. Establishment of an ovarian metastasis model and possible involvement of E‐cadherin down‐regulation in the metastasis , 2008, Cancer science.
[46] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[47] S. Shirasawa,et al. Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA. , 2012, Carcinogenesis.
[48] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[49] R. Ballotti,et al. The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion , 2012, PloS one.
[50] J. Testa,et al. Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.
[51] Sara M. Johnson,et al. Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. , 2010, Journal of the American College of Surgeons.
[52] L. Mauro,et al. Prognostic value of E‐cadherin, beta‐catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma , 2006, Journal of surgical oncology.
[53] C. Damodaran,et al. Notch-1 Inhibition by Withaferin-A: A Therapeutic Target against Colon Carcinogenesis , 2010, Molecular Cancer Therapeutics.
[54] Alfonso Bellacosa,et al. AKT plays a central role in tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[55] Alfonso Bellacosa,et al. Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways , 2005, Oncogene.